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A method for the preparative isolation of peroxisomes from the livers of rat, guinea pig, and 
mouse, and also from rat kidney is described. The light mitochondrial fraction, i.e., particles 
sedimenting between 33,000 and 250,OOOg-min, or the postnuclear supematant of liver or 
kidney, is subjected to a 20-50% Me&amide density gradient ultracentrifugation in a vertical 
rotor. After centrifugation, the peroxisomes (marker enzyme catalase and dihydroxyacetone 
phosphate acyhransferase) sedimented as a band near the bottom of the tube (p = 1.22 g/ml). 
From the distribution of different marker enzymes and also from the morphometric examinations, 
it was demonstrated that the isolated peroxisomes are not contaminated with lysosomes, 
mitochondria, or microsomes. 0 1985 Academic press, IIK. 
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Peroxisomes were first described by de 
Duve and co-workers as hepatic and renal 
subcellular organelles (0.5- 1 pm diameter) 
containing catalase and H20z-producing ox- 
idases (1,2). Novikoff and co-workers de- 
scribed the widespread occurrence of some- 
what smaller (0.1-0.5 pm) catalase-containing 
particles, designated as microperoxisomes, in 
a variety of different tissues (3,4). Because of 
their similarities in size and density with 
other organelles, especially with lysosomes in 
liver and kidney, the peroxisomes are difficult 
to isolate from tissue homogenates by either 
differential or density gradient centrifugations 
(1,5). The most widely used method to 
isolate peroxisomes from liver is that intro- 
duced by Leighton et al. (5) where peroxi- 
somes are separated from lysosomes by cen- 
trifugation in a sucrose density gradient after 
first lowering the density of liver lysosomes 
by pretreating the animals with Triton WR- 
1339. We have successfully used that method 
to show that some lipid-metabolizing en- 
zymes such as dihydroxyacetone phosphate 
(DHAP)’ acyltransferase are present in liver 
peroxisomes (6). This method, however, can- 
not be used to isolate peroxisomes from 
other organs, such as kidney. In addition, the 
treatment of animals with the detergent Tri- 
ton WR-1339 has been shown to alter the 
activities of different peroxisomal enzymes 
(7). A number of other density gradient 
centrifugation methods using either sucrose 
(g-lo), Metrizamide (2-[3-acetamido-5-N- 
methylacetamido - 2,4,6-triodobenzamido[-2- 
deoxy-D-glucose) ( 11,12), or Percoll ( 13- 15) 
solutions have been described for the isolation 
of peroxisomes from normal animals. Most 
of these methods, however, yield peroxi- 
somes which are contaminated with varying 
amounts of other organelles. In 198 1 we 
described a method for isolating peroxisomes 
from rat and guinea pig livers using Metri- 
zamide density gradient centrifugation in a 
vertical rotor and presented preliminary data 
’ Abbreviations used: DHAP, dihydroxyacetone phos- 
phate; GP, sn-glycerol-3-phosphate. 
233 0003-2697185 $3.00 
Copyright 0 1985 by Academic Press. Inc. 
All rights of reproduction in any form reserved. 
234 HAJRA AND WU 
which indicate that the isolated peroxisomes 
are uncontaminated with other organelles 
( 16). We also successfully used this method 
to isolate pcroxisomes from kidney. The de- 
tails of the method and the results are pre- 
sented here. 
MATERIALS 
Palmitoyl CoA, DHAP, cytochrome c, 
D-glucose-6-phosphate, &lycerophosphate, 
succinate, and isocitrate were obtained from 
Sigma Chemical Company (St. Louis, MO.). 
sn-Glycerol-3-phosphate (GP) was from Cal- 
Biochem-Behring. Analytical-grade Metri- 
zamide2 (Nyegaard & Co.) was obtained from 
Accurate Chemical & Scientific Research 
Corporation (Westbury, N. Y.). [32P]- 
DHAP and [32P]GP were prepared by the 
enzymatic phosphorylation of dihydroxyac- 
etone and glycerol, respectively, with [y- 
32P]ATP, as described previously (17). [l- 
14C]Palmitoyl CoA was chemically prepared 
from [ l-‘4C]palmitic acid and CoASH as 
described by Bishop and Hajra (18). Other 
materials were the same as described before 
(6,17). 
METHODS 
Preparation of liver and kidney subcellular 
fractions. The subcellular fractions were pre- 
pared by differential centrifugation of the 
organ homogenates essentially by the method 
of de Duve and co-workers ( 19). The animals 
were lightly anesthetized with diethyl ether 
and decapitated, and the liver or kidneys 
were quickly extracted and chilled on ice. 
The organs were homogenized (one-stroke) 
in 3 vol (ml/g) of ice-cold 0.25 M sucrose 
containing Tris-HCl buffer (pH 7.4, 10 mM) 
and EDTA (1 .O mM in a glass homogenizer 
with a Teflon pestle (.4rthur Thomas Co.) at 
1500 rpm as described before (i9,20). The 
homogenate was filtered through cheesecloth 
and then centrifuged at 4°C for 10 min at 
* The analytical-grade Metrizamide, not the centrifu- 
gation grade (Metrizamide-C), must be used for the 
isolation of peroxisomes uncontaminated with lysosomes 
and mitoehondria. 
800g (Sorvall RC2B centrifuge). The super- 
natant was saved and the resdue was reho- 
mogenized as above in 3 vol (ml/g of origina 
tissue) of the cold sucrose-tris-EDTA solu- 
tion and recentrifuged at 8OOg for 10 min. 
This second supernatant was combined with 
the first supernatant and when required this 
combined ( 1:6 homogenate) postnuclear su- 
pematant (S-l) was used for the isolation of 
peroxisomes by the Metrizamide density gra- 
dient centrifugation (see later). For the iso- 
lation of the light mitochondrial or “L” 
fraction of de Duve et al. ( 19), the residue 
obtained after the second centrifugation was 
rehomogenized as before in 3 vol of sucrose- 
Tris-EDTA and recentrifuged (SOOg, 10 min). 
The residue was discarded and the superna- 
tant was combined with the other supema- 
tants. “L” fraction was isolated from this 
combined postnuclear supematant ( 1:9 ho- 
mogenate) by differential centrifugation 
(fraction sedimenting between 33,000 and 
250,00Og-min) as described by de Duve and 
co-workers (5,19). The ‘I” fraction was 
FIG. 1. Schematic representation of the banding pat- 
terns of “L” fraction after centrifugation in a 20-5096 
Metrizamide density gradient in a vertical rotor. 
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FIG. 2. Distribution pattern of different enzymes of 
rat liver light mitochondrial (L) fraction (24 mg protein) 
after centrifugation in a linear Me&amide density 
gradient (20-50% Metrizamide, density 1.11 to 1.28 g/ 
ml). Following centrifugation in a vertical rotor and 
fraction collection (see text for details) each fraction was 
assayed for different subcellular marker enzymes. The 
recovery of each enzyme was 106% for catalase (peroxi- 
somal marker enzyme), 92% for acid phosphatase (lyso- 
somal marker enzyme), 85% for succinate-cytochrome 
c reductase (mitochondrial marker enzyme), 94% for 
ghicose&phosphatase (microsomal marker enzyme), 95% 
for DHAP acyltransferase (DHAPAT), and 97% for 
protein. B, Bottom of gradient (50% Metrizamide); T, 
top of the gradient (20% Metrizamide). 
washed twice (25,OOOg, 10 min) with the 
homogenizing buffer (sucrose-Tris-EDTA) 
and then suspended in the same buffer in 
such a way that 1 ml of the suspension 
contained the “L” fraction obtained from 4 
g of tissue. 
Metrizamide density gradient centrifuga- 
tion. The 20-50% linear Metrizamide gra- 
dients were prepared directly in the Beckman 
Quick Seal centrifuge tubes (25 X 89 mm). 
Six different Metrizamide solutions of in- 
creasing densities (20, 26, 32, 38, 44, and 
50%) were layered vertically below each other 
by injecting these solutions (6.6 ml each of 
increasing densities for 40-ml tube) to the 
bottom of the centrifuge tube through a long 
hollow needle from the top. The narrow 
openings of the tubes were sealed with Par- 
afilm and the tubes were slowly and gently 
tilted to the horizontal position and kept at 
4°C for 15-20 h. Before the loading, the 
tubes were slowly returned to the vertical 
positions, and then about l-2 ml of Metri- 
zamide solution from the top was removed 
and replaced with the corresponding volume 
of S-l or “L” suspensions with the aid of a 
Beckman sample application apparatus. Gra- 
dients were also sometimes made by a con- 
ventional gradient making apparatus (Bio- 
Rad Model 230) using 20 and 50% Metriza- 
mide solutions. However, this latter method 
was found to be more tedious and somewhat 
less reproducible than the method described 
above. 
After the loading, the tubes were heat 
sealed using Quick Seal tube sealer (Beckman) 
and centrifuged in a vertical rotor (Beckman 
VTi50) using an ultracentrifuge (Beckman 
L8-70) at a total centrifugal force (u2t) of 6.3 
X 10” radians2/sec (13O,OOOg,, for 65-70 
min). After centrifugation the tubes were 
opened by cutting off the seal and the contents 
were pumped out from the bottom by a 
peristaltic pump through a long hollow needle 
which was inserted from the top. Fractions 
of about 2 ml were collected in a fraction 
collector and the fractions were quick-frozen 
in a dry ice-acetone bath and stored at 
-20°C. 
Enzyme assays. Established procedures 
have been used to assay the marker enzymes 
such as catalase (21), acid phosphatase 
(22,23), succinate-cytochrome c reductase 
(24) and glucose-6-phosphatase (25). Uric 
acid oxidase was determined as described by 
Leighton et al. (5) after complete removal of 
Metrizamide by extensive dialysis of the frac- 
tions against 0.25 M sucrose. Because of its 
strong absorption in the uv region, Metriza- 
mide interferes with the uric acid oxidase 
assay at 292 nm. Monoamine oxidase was 
assayed using labeled tyramine as described 
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by W ‘urtman and Axelrod (26). DHAP acyl- CoA synthase activity was measured by 
u-an3 Ferase and GP acyltransferase activities filter paper assay method of Roughan 
were determined by measuring the labeled Slack (27) and palmitoyl CoA hydrolase 
lipids formed either from [32P]DHAP or from assayed as described by Berge (28). Cyan 
[32P]( SP and palmitoyl CoA (6,17). Palmitoyl insensitive fatty acid P-oxidation was d< 
FIG. 3. Morphological appearance of rat liver (A) L fraction and (B) purified peroxisomal fraction when 





minr :d by measuring the acid-soluble radio- A radiometric assay was develope :d to 
activ ity formed from [l-‘4C]palmitoyl CoA measure low GP dehydrogenase activi .tY in 
as dl es&bed by Lazarow (29). Isocitrate de- the peroxisomal fractions. The incub lati on 
hydr ogenase was assayed as described by mixture contained Tricine buffer (pH 7. 3, 50 
Ken rberg (30). mM), NADH (0.3 mM), [32P]DHAP (( I.5 
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FIG. 4. Distribution pattern of different enzymes of 
rat kidney ‘I” fraction after centrifugation in Metriza- 
mide density gradient similar to that described in Fig. 2. 
GPAT, GP acyltransferase. 
mM, 8 X lo5 cpm), and the fractions (2-20 
pg protein) in a total volume of 0.1 ml. The 
mixture was incubated at 37°C for 5 min 
and the reaction was stopped by adding 50 
~1 of 0.3 M oxalate buffer (pH 1.5). An 
aliquot (20 ~1) of the mixture was subjected 
to high-voltage paper electrophoresis at pH 
1.5 to separate the product [32P]GP from 
[32P]DHAP (3 1). After separation, the radio- 
active spots on the paper were localized by 
radioautography and cut out, and the ra- 
dioactivities in these spots were quantified 
by liquid scintillation counting (32). The 
reaction rate for this assay was found to be 
linear with time (up to 5 min) and protein 
concentrations (up to 30 pg protein). 
Other methods. Protein was determined 
either by the dye-binding method (33) or by 
a modified Lowry (34) assay in which the 
protein was first coprecipitated with deoxy- 
cholate by trichloroacetic acid. This was done 
to remove the Metrizamide which interferes 
with the Lowry assay procedure (11,33). The 
densities of Metrizamide solutions were de- 
termined either by directly weighing a mea- 
sured volume of the solutions or by measuring 
the absorbance of the solutions (after appro- 
priate dilutions ) at 240 nm (absorbance 
= 3.12 X lo4 M-’ cm-‘). For electron mi- 
croscopy the fractions in Metrizamide were 
fixed in 1.5% glutaraldehyde at 4°C. The 
fractions were then filtered through Millipore 
filters (0.025-pm pore size) under N2 pressure 
as described by Baudhuin (22). The subcel- 
lular particles collected on the filters were 
then postfixed in osmium tetroxide solution 
(1% Os04 in 50 mM phosphate buffer at pH 
7.4) for 2 h and then dehydrated by serially 
passing the filters through solutions of in- 
creasing ethanol concentrations. After the 
final immersion in 100% ethanol, the filters 
are embedded in Spurr resin. Thin sections 
were cut on an LKB microtome and viewed, 
after counterstaining lightly with lead citrate 
and uranyl acetate, in a Philips 400 electron 
microscope. All other procedures were the 
same as described previously (6,17,20). 
RESULTS 
Isolation of Peroxisomes from Rat Liver 
“L” Fraction 
After density gradient centrifugation, the 
peroxisomes from the rat liver “L” fraction 
form a diffuse band near the bottom of the 
tube (p = 1.22) well separated from other 
organelles (Fig. 1). This is clearly seen in the 
distribution profile of different marker en- 
zymes in this Metrizamide gradient (Fig. 2). 
Peroxisomes (marker enzyme catalase) are 
localized mainly in the bottom half of the 
tube (fractions 4-7) whereas lysosomes 
(marker enzyme acid phosphatase), mito- 
chondria (marker enzyme succinate-cyto- 
chrome c reductase), and microsomes (marker 
enzyme glucose-6-phosphatase) are all local- 
ized mainly in the top half (above fraction 
9) of the tube. A small amount of catalase is 
also present at the top of the gradient which 
is probably due to soluble catalase released 
from the breakdown of a small fraction of 
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peroxisomes during handling of the “L” frac- 
tion. DHAP acyltransferase, which has been 
shown to be a peroxisomal enzyme (6,16,20), 
sediments with the catalase-containing par- 
ticles (Fig. 2). The enrichment (relative spe- 
cific activity) of catalase and DHAP acyl- 
transferase in the peak fractions (fractions 5 
and 6) starting from the “L” fraction is about 
lo- and 12-fold, respectively. Uric acid oxi- 
dase, another peroxisomal enzyme, is also 
found to sediment with the catalase-contain- 
ing particles (data not shown; however, see 
Fig. 7). A part of cellular glycerophosphate 
dehydrogenase has been reported to be pres- 
ent in peroxisomes (35). This is confirmed 
here as shown in Fig. 2. About 16% of total 
glycerophosphate dehydrogenase present in 
the “L” fraction is found to be present in 
peroxisomes. Similarly, as reported before 
(5), a small (6%) but measurable amount of 
isocitrate dehydrogenase (NADPH specific) 
was also found to be present in peroxisomes 
(Fig. 2). 
The Metrizamide from peroxisomes can 
be removed by diluting the fractions with 
0.25 M sucrose and then pelleting the per- 
oxisomes by centrifugation at 100,OOOg for 
30 min. A portion of the peroxisomes, how- 
ever, is damaged by this procedure as seen 
by the release of lo-20% catalase in the 
supernatant. A more gentle procedure for the 
removal of Metrizamide is to dialyze the 
fractions against 0.25 M sucrose at 4°C for 
lo- 12 h. Peroxisomes isolated by such pro- 
cedure are intact since it was found that all 
the catalase is particulate bound and cannot 
be inactivated by brief trypsin treatment (10 
min at 25°C) unless detergent (Triton X- 
100) is also present. 
Morphological examination of the peroxi- 
somal fraction isolated by this Metrizamide 
gradient centrifugation technique also showed 
that the peroxisomes are uncontaminated 
with other subcellular organelles. This is 
shown in Fig. 3 where it is seen that though 
the starting “L” fraction contained large 
numbers of mitochondria, lysosomes, and 
endoplasmic reticulum residues (Fig. 3A), 
these organelles are practically absent in the 
isolated peroxisomal fraction (Fig. 3B). 
Isolation of Peroxisomes from Rat Kidney 
Peroxisomes from rat kidney “L” fraction 
can also be isolated by a similar Metrizamide 
density gradient centrifugation in a vertical 
rotor. The results are shown in Fig. 4. As in 
the rat liver, the peroxisomes (catalase-con- 
taining particles) sedimented to the bottom 
half of the tube away from mitochondria, 
lysosomes, and microsomes (Fig. 4). Mor- 
phometric examination also shows that the 
isolated peroxisomes are pure (Fig. 5). 
Isolation of Peroxisomes from Mouse Liver 
Postnuclear Supernatant 
The procedure described above can be 
used to isolate peroxisomes from guinea pig 
liver “L” fraction (16) and also from the 
liver postnuclear supematant in which most 
of the other subcellular organelles are also 
present. This is shown by using mouse liver 
in Figs. 6 and 7. It is seen that when mouse 
liver postnuclear homogenate is loaded on a 
linear Metrizamide density gradient and spun 
in a vertical rotor, the peroxisomes are sedi- 
mented as a band close to the bottom of the 
tube well separated from other organelles. 
The two marker enzymes for peroxisomes, 
catalase and urate oxidase, are cosedimented 
at the same position. However, a large pro- 
portion of catalase, compared to that of “L” 
fraction, is present at the top of the gradient. 
This may represent soluble and/or microper- 
oxisomal-bound catalase. DHAP acyltrans- 
ferase measured at both pH 5.5 and pH 7.5 
has a distribution pattern very similar to that 
of catalase (Fig. 7). In contrast GP actyltrans- 
ferase, which is known to be present in 
mitochondria and microsomes, is absent from 
the peroxisomal fraction (Fig. 7). The cya- 
nide-insensitive fatty acid P-oxidation enzyme 
system, which is known to be peroxisomal 
(36), corn&rates with sedimentable catalase- 
containing particles. The lysosomes (marker 
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FIG. 5. Morphological appearance of rat kidney (A) L fraction and (B) the combined peroxisomal 
fractions (see text for details). Bar = 1 pm. 
enzyme acid phosphatase) are clearly sepa- palmitoyl CoA hydrolase, the activity of 
rated out from peroxisomes (Fig. 6) but which has been shown to be increased by 
fractions of both the microsomes (marker peroxisome proliferators (38), is not present 
enzyme glucose-6-phosphatase) and mito- in peroxisomes (Fig. 6). In separate experi- 
chondria (marker enzymes succinate-cyto- ments (data not shown), the combined per- 
chrome c reductase and monoamine oxidase) oxisomes fraction was found to be uncon- 
migrate close to (but well separated from) taminated with plasma membrane (marker 
the peroxisomal peak. A small fraction (4.0%) enzyme S-nucleotidase) and golgi bodies 
of mitochondrial outer membrane (marker (marker enzyme galactosyl transferase). In 
enzyme monoamine oxidase) contaminates the peak fractions catalase and DHAP acyl- 
the peroxisomal fraction (Fig. 7). The results transferase are seen (Fig. 8) to be enriched 
in Fig. 6 also confirm the presence of pal- (i.e., relative specific activity) by 25 to 30- 
mitoyl CoA ligase in peroxisomes which has fold from S-l (30- to 35fold from the whole- 
been reported by Krisans et al. (37). However, liver homogenate). 
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FIG. L-Continued. 
DISCUSSION 
It is clear from the results presented above 
that on centrifugation the liver and kidney 
peroxisomes migrate faster than any other 
organelle and appear as a distinct band in 
this Metrizamide density gradient. The en- 
richment of catalase from rat liver homoge- 
nate in the peak peroxisomal fractions is 
about 40- to 50-fold, which is similar to that 
reported by other workers (5). From the 
distribution profiles of the marker enzymes, 
it is seen that the main peroxisome fractions 
contain very little contamination from any 
other subcellular fractions even when the 
total postnuclear homogenate was used for 
the separation. Only on the low-density side 
of the peroxisome band is there some con- 
tamination by microsomes due to the pres- 
ence of the microsomal shoulder peak. How- 
ever, part of the contamination is probably 
due to the fraction collection method em- 
ployed (through a hypodermic needle inserted 
from the top) which caused some mixing 
inside the vertical needle and tube due to the 
inversion of the gradient. Visually, a clear 
demarcation was seen between the pale brown 
peroxisomal band and the reddish micro- 
somal band after centrifugation (Fig. 1). 
These results show that peroxisomes from 
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FIG. 6 and 7. Distribution patterns of different enzymes in two different preparations of mouse liver S- 
1 fraction (42 and 45 mg protein; see Fig. 2 legend for details). The recovery of the marker enzymes is 
between 90-105%. 
kidney can also be isolated by this method 
in a relatively pure state. Kidney peroxisomes 
uncontaminated with other organelles have 
not been isolated before. It is also seen that, 
as in liver, DHAP acyltransferase in kidney 
has a very similar distribution pattern to that 
of catalase, indicating that this enzyme is 
exclusively localized in peroxisomes. There- 
fore, it seems DHAP acyltransferase may be 
used as a peroxisomal membrane marker 
enzyme. The similarities of distribution of 
activity of DHAP acyltransferase when mea- 
sured at pH 5.5 and 7.5 further indicate that 
a part of pH 7.5 activity is not due to the 
nonspecificity of GP acyltransferase. The dis- 
tribution of GP acyltransferase in the Metri- 
zamide gradient fractions is quite different 
from that of DHAP acyltransferase (Figs. 4 
and 7). 
As mentioned before, Metrizamide density 
gradient centrifugation has been used by a 
number of authors for the preparative isola- 
tion of peroxisomes from liver. Wattiaux et 
al. (11) first demonstrated that lysosomes 
can be separated from peroxisomes in Met- 
rizamide density gradient centrifugation. 
Bronfman et al., using isopycnic Metrizamide 
density gradient centrifugation in a swinging- 
bucket rotor, isolated peroxisomes from liver 
( 12). Similar methods have been used by 
Small et al. (39) and Crane et al. (40) to 
isolate peroxisomes from liver and kidney. 
In all these methods the isolated peroxisomes 
are contaminated with varying amounts of 
microsomes and other organelles. This is 
probably because of long periods of centrif- 
ugation employed at high hydrostatic pressure 
for the isopycnic operation. The peroxisomes 
separate from lysosomes and mitochondria 
in the Metrizamide medium probably because 
peroxisomes, but not lysosomes or mito- 
chondria, are permeable to Metrizamide. In 



















FIG. 8. The enrichment of the mouse liver peroxisomal 
enzymes after Metrizamide density gradient centrifuga- 
tion. The enrichment is calculated as the relative specific 
activities of these enzymes in these fractions compared 
to those of the starting S-l fraction. 
other words, as defined by de Duve and co- 
workers, the Me&amide space of peroxi- 
somes is much larger than that of lysosomes 
or mitochondria (4 1,42). Therefore, during 
centrifugation in the vertical rotor, due to 
the short path length, peroxisomes sediment 
to their intrinsic equilibrium density more 
quickly than do lysosomes and mitochondria. 
The microsomal vesicles because of their 
smaller size sediment at a slower rate, i.e., 
rate-dependent banding as defined by Reid 
and Williamson (43), than do peroxisomes. 
Longer centrifugation times than employed 
here results in more microsomal contami- 
nation of the peroxisome fractions. 
The question naturally arises whether sim- 
ilar Metrizamide density gradient centrifu- 
gation can be employed to isolate microper- 
oxisomes from other tissues. Our preliminary 
results using developing rat brain indicate 
that, though it is possible to enrich the mi- 
croperoxisomes from brain homogenate using 
such gradients, the microperoxisomes cannot 
be isolated completely free of microsomes 
(K. 0. Webber and A. K. Hajra, unpublished 
results). This is probably due to the similarity 
in sizes of microperoxisomes and endo- 
plasmic reticulum vesicles. 
Sucrose and Percoll density gradient cen- 
trifugation have also been used to isolate 
peroxisomes from liver (5,8-10,13-15). The 
peroxisomes isolated in Percoll gradients are 
contaminated with other organelles, especially 
with mitochondria. Also, it is difficult to 
separate the insoluble Percoll (colloidal silica 
particles) from the subcellular organelles. 
Similarly, peroxisomes free from lysosomes 
can be isolated by sucrose density gradient 
centrifugation only when the rats are pre- 
treated by injecting Triton WR- 1339 to lower 
the density of lysosomes. A special rotor 
(Beaufay rotor) is also needed to purify per- 
oxisomes by this method (10). Metrizamide 
is superior to sucrose because of its lower 
osmolarity at the same density of the solutions 
(11,42). Also, in a vertical rotor the hydro- 
static pressure during the centrifugation is 
much lower than that exerted in swinging- 
bucket rotors (13). From the results presented 
here, it is evident that Metrizamide density 
gradient centrifugation in a vertical rotor is 
most suited to isolation of pure peroxisomes 
from normal liver and kidney in a relatively 
short period of time. The only disadvantage 
of this procedure is the high cost of Metri- 
zamide. However, recently a compound, Ny- 
codenz (5-[N2,3dihydroxypropyl acetamido)- 
2,4,6-tri-iodo-N,N’-bis[2,3dihydroxypropyl]- 
isophthalamide), similar in structure to Me- 
trizamide, has been developed (Nyegaard & 
Co.) which is somewhat less expensive. Pre- 
liminary experiments in this laboratory (A. 
K. Hajra and D. Wu, unpublished results) 
and in other laboratories3 (44) indicate that 
Nycodenz, instead of Metrizamide, may be 
used for the isolation of peroxisomes. 
3 Peroxisomes isolated by the method described by 
Osmundsen (44) is contaminated with microsomes. This 
is probably due to the step gradient used for the centrifugal 
separation of peroxisomes. We found that by using a 
linear gradient, as described above, the peroxisomes are 
uncontaminated with microsomes. 
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